Who has invested in Mural Oncology?

Alkermes are named among the investors backing Mural Oncology.

Mural Oncology Funding: $275M Raised, Seed (2024)

Mural Oncology funding overview

Mural Oncology is based in Boston, MA. Mural Oncology has raised $275M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Seed announced in November 2024. The round record for Mural Oncology runs through 2024; nothing later has been disclosed. Investors on record include Alkermes.

Mural Oncology at a glance

Total raised: $275M
Latest round: Seed
Latest round date: November 2024
Headquarters: Boston, MA
Notable investors: Alkermes

Frequently asked about Mural Oncology funding

How much has Mural Oncology raised?: Mural Oncology has raised $275M in total disclosed funding across the rounds on record.
Who has invested in Mural Oncology?: Alkermes are named among the investors backing Mural Oncology.
What was the latest Mural Oncology funding round?: The most recent disclosed round is a Seed, announced in November 2024.
Where is Mural Oncology based?: Mural Oncology is based in Boston, MA.
When did Mural Oncology last raise?: The last disclosed Mural Oncology round closed in November 2024 at Seed.

Every Mural Oncology figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Boston at a similar stage.

Mural Oncology Funding: $275M Raised, Seed (2024)

Mural Oncology funding overview

Mural Oncology at a glance

Frequently asked about Mural Oncology funding

Companies related to Mural Oncology (18)

Browse related funding lists (5)